|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
|
TWI312285B
(en)
*
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
US9533938B2
(en)
|
2007-01-31 |
2017-01-03 |
Biosuccess Biotech Co., Ltd. |
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
WO2008095221A1
(en)
|
2007-02-07 |
2008-08-14 |
Gosforth Centre (Holdings) Pty Ltd |
Treatment of adhd
|
|
EP2331088A4
(en)
|
2008-08-06 |
2011-10-12 |
Gosforth Ct Holdings Pty Ltd |
COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
|
|
DK3260118T3
(da)
|
2008-10-16 |
2021-04-19 |
Univ Johns Hopkins |
Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
|
|
WO2010094289A1
(en)
*
|
2009-02-20 |
2010-08-26 |
Aarhus Universitet |
Allosteric binding compounds
|
|
EP2509596B1
(en)
|
2009-12-08 |
2019-08-28 |
Case Western Reserve University |
Gamma aminoacids for treating ocular disorders
|
|
WO2011143721A1
(en)
*
|
2010-05-21 |
2011-11-24 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating neurodegenerative disorders
|
|
US8609849B1
(en)
|
2010-11-30 |
2013-12-17 |
Fox Chase Chemical Diversity Center, Inc. |
Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
|
|
BR112013020283A2
(pt)
*
|
2011-02-09 |
2016-07-19 |
Univ Johns Hopkins |
"uso de inibidor de proteína de vesícula sináptica 2a (sv2a), valproato, levetiracetam, brivarecetam e seletracetam no tratamento de deficiência cognitiva, bem como composição farmacêutica compreendendo os mesmos"
|
|
US10085414B2
(en)
|
2011-05-19 |
2018-10-02 |
Gilrose Pharmaceuticals, Llc |
Pre-frontal cortex processing disorder speech, gait and limb impairments treatment
|
|
US9682073B2
(en)
|
2011-05-19 |
2017-06-20 |
Gilrose Pharmaceuticals, Llc |
Pre-frontal cortex processing disorder gait and limb impairments treatment
|
|
US20140163070A1
(en)
|
2012-05-17 |
2014-06-12 |
Bruce Roseman |
Treatment for cerebral palsy impaired speech in children
|
|
US8883815B2
(en)
|
2011-05-19 |
2014-11-11 |
Gilrose Pharmaceuticals, Llc |
Treatment for cerebral palsy impaired speech in children
|
|
US9040082B2
(en)
|
2011-06-24 |
2015-05-26 |
K-Pax Pharmaceuticals, Inc. |
Compositions and methods for treatment of chronic fatigue
|
|
GB201111712D0
(en)
*
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
RU2480214C1
(ru)
*
|
2011-09-22 |
2013-04-27 |
Валентина Ивановна Ахапкина |
Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
|
|
MX373291B
(es)
*
|
2012-01-18 |
2020-05-06 |
Biosuccess Biotech Co Ltd |
Composiciones y metodos para el uso de ésteres de forbol
|
|
EP2806867A4
(en)
*
|
2012-01-27 |
2015-09-02 |
Catalyst Pharmaceutical Partners Inc |
METHOD FOR TREATING TOURETTE SYNDROME WITH GABA AMINO TRANSFERASE INACTIVORS
|
|
WO2013139292A1
(zh)
*
|
2012-03-23 |
2013-09-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种含辛弗林和托吡酯的联合产品
|
|
CN103316026B
(zh)
|
2012-03-23 |
2016-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
含芬特明和托吡酯的联合产品及其制备方法
|
|
TW201408294A
(zh)
*
|
2012-07-05 |
2014-03-01 |
Merz Pharma Gmbh & Co Kgaa |
(r)-苯基披喇瑟盪於治療帕金森氏症之用除
|
|
JP6389177B2
(ja)
|
2012-08-21 |
2018-09-12 |
ヤンセン ファーマシューティカ エヌ．ベー． |
オランザピンハプテンに対する抗体及びその使用
|
|
US9494608B2
(en)
|
2012-08-21 |
2016-11-15 |
Janssen Pharmaceutica Nv |
Antibodies to olanzapine and use thereof
|
|
ES2652641T3
(es)
|
2012-08-21 |
2018-02-05 |
Janssen Pharmaceutica Nv |
Haptenos de aripiprazol y su uso en inmunoensayos
|
|
EP3462173B1
(en)
|
2012-08-21 |
2021-03-31 |
Janssen Pharmaceutica NV |
Antibodies to risperidone and use thereof
|
|
ES2788716T3
(es)
|
2012-08-21 |
2020-10-22 |
Janssen Pharmaceutica Nv |
Anticuerpos para haptenos de quetiapina y uso de los mismos
|
|
JP2015529199A
(ja)
|
2012-08-21 |
2015-10-05 |
オルソ−クリニカル ダイアグノスティクス，インコーポレイティド |
パリペリドンハプテンに対する抗体及びその使用
|
|
CA2882490A1
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to paliperidone and use thereof
|
|
CA2882562C
(en)
|
2012-08-21 |
2019-08-27 |
Eric Hryhorenko |
Antibodies to aripiprazole and use thereof
|
|
ES2978909T3
(es)
*
|
2012-08-21 |
2024-09-23 |
Janssen Pharmaceutica Nv |
Anticuerpos contra haptenos de aripiprazol y uso de los mismos
|
|
ES2654413T3
(es)
|
2012-08-21 |
2018-02-13 |
Janssen Pharmaceutica, N.V. |
Anticuerpos a quetiapina y uso de los mismos
|
|
CN104736565B
(zh)
|
2012-08-21 |
2019-03-12 |
詹森药业有限公司 |
利培酮半抗原的抗体及其用途
|
|
US20140206667A1
(en)
|
2012-11-14 |
2014-07-24 |
Michela Gallagher |
Methods and compositions for treating schizophrenia
|
|
US9265458B2
(en)
|
2012-12-04 |
2016-02-23 |
Sync-Think, Inc. |
Application of smooth pursuit cognitive testing paradigms to clinical drug development
|
|
US9380976B2
(en)
|
2013-03-11 |
2016-07-05 |
Sync-Think, Inc. |
Optical neuroinformatics
|
|
US8652527B1
(en)
|
2013-03-13 |
2014-02-18 |
Upsher-Smith Laboratories, Inc |
Extended-release topiramate capsules
|
|
US9101545B2
(en)
|
2013-03-15 |
2015-08-11 |
Upsher-Smith Laboratories, Inc. |
Extended-release topiramate capsules
|
|
WO2014144663A1
(en)
|
2013-03-15 |
2014-09-18 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
|
AU2014228512A1
(en)
|
2013-03-15 |
2015-10-01 |
Agenebio, Inc. |
Methods and compositions for improving cognitive function
|
|
KR20210113429A
(ko)
|
2013-03-15 |
2021-09-15 |
멜리어 파마슈티칼스 투, 엘엘씨. |
시드노카브 또는 이의 약학적으로 허용되는 염을 포함하는 약학적 조성물 및 수면 장애를 치료하는 방법
|
|
US9549909B2
(en)
|
2013-05-03 |
2017-01-24 |
The Katholieke Universiteit Leuven |
Method for the treatment of dravet syndrome
|
|
EP2875810A1
(en)
*
|
2013-11-20 |
2015-05-27 |
Biocodex |
Pharmacological treatment of obsessive-compulsive disorder using Stiripentol or a similar compound
|
|
EP2886116A1
(en)
*
|
2013-12-18 |
2015-06-24 |
Biocodex |
Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity
|
|
AU2014371437B2
(en)
*
|
2013-12-25 |
2020-01-30 |
Fujimoto Co., Ltd. |
Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
|
|
US20170173039A1
(en)
*
|
2014-04-02 |
2017-06-22 |
Yale University |
Compositions and methods to treat addiction
|
|
US10610512B2
(en)
|
2014-06-26 |
2020-04-07 |
Island Breeze Systems Ca, Llc |
MDI related products and methods of use
|
|
GB201416017D0
(en)
*
|
2014-09-10 |
2014-10-22 |
New Royal Holloway & Bedford |
An Anticonvulsant Compound
|
|
KR102245345B1
(ko)
*
|
2014-09-29 |
2021-04-28 |
조게닉스 인터내셔널 리미티드 |
의약품 배포 제어를 위한 제어 시스템
|
|
KR20210095734A
(ko)
*
|
2015-01-28 |
2021-08-02 |
주식회사 제네리스코리아 |
신경정신계 장애의 치료를 위한 조성물 및 방법
|
|
CA2986598C
(en)
|
2015-05-22 |
2023-09-26 |
Agenebio, Inc. |
Extended release pharmaceutical compositions of levetiracetam
|
|
JP6930969B2
(ja)
*
|
2015-07-08 |
2021-09-01 |
ギルローズ ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
前頭前皮質プロセシング疾患、歩行及び四肢障害の治療
|
|
CN106361734A
(zh)
*
|
2015-07-25 |
2017-02-01 |
云南帕精生物科技有限公司 |
一类治疗精神分裂症药物
|
|
US10662146B2
(en)
*
|
2015-09-15 |
2020-05-26 |
Praxis Bioresearch, LLC |
Prodrugs of fencamfamine
|
|
CN106562945A
(zh)
*
|
2015-10-11 |
2017-04-19 |
云南帕精生物科技有限公司 |
一类治疗帕金森病药物
|
|
EP3386491B1
(en)
*
|
2015-12-11 |
2021-12-08 |
Aarhus Universitet |
Rufinamide for use in the treatment of myotonia
|
|
EP3390455A1
(en)
|
2015-12-17 |
2018-10-24 |
Janssen Pharmaceutica NV |
Antibodies to quetiapine and use thereof
|
|
CN108431040B
(zh)
|
2015-12-17 |
2022-07-26 |
詹森药业有限公司 |
利培酮的抗体及其用途
|
|
WO2017112701A1
(en)
|
2015-12-22 |
2017-06-29 |
Zogenix International Limited |
Metabolism resistant fenfluramine analogs and methods of using the same
|
|
PT4293009T
(pt)
|
2015-12-22 |
2025-09-08 |
Zogenix International Ltd |
Composições de fenfluramina e métodos de preparação das mesmas
|
|
CN105456214A
(zh)
*
|
2015-12-30 |
2016-04-06 |
蔡惠文 |
甲磺酸沙芬酰胺片
|
|
EP3455203B1
(en)
*
|
2016-05-12 |
2021-09-22 |
Research Triangle Institute |
Vinylogous phenethylamines as neurotransmitter releasers
|
|
AU2017315273B2
(en)
|
2016-08-24 |
2021-04-29 |
Zogenix International Limited |
Formulation for inhibiting formation of 5-HT 2B agonists and methods of using same
|
|
CA3062247A1
(en)
*
|
2017-05-09 |
2018-11-15 |
Zogenix International Limited |
Methods of treating doose syndrome using fenfluramine
|
|
PT3661491T
(pt)
|
2017-08-03 |
2025-07-24 |
Ezekiel Golan |
3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica
|
|
US10682317B2
(en)
|
2017-09-26 |
2020-06-16 |
Zogenix International Limited |
Ketogenic diet compatible fenfluramine formulation
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
AU2018354181A1
(en)
*
|
2017-10-23 |
2020-03-12 |
Cerebral Therapeutics LLC |
High concentration valproic acid solutions for treating neurological disorders
|
|
CA3081199A1
(en)
*
|
2017-11-14 |
2019-05-23 |
Osaka University |
Cognitive impairment diagnostic apparatus and cognitive impairment diagnostic program
|
|
EP3790537A1
(en)
|
2018-05-11 |
2021-03-17 |
Zogenix International Limited |
Compositions and methods for treating seizure-induced sudden death
|
|
AU2019384963B2
(en)
|
2018-11-19 |
2022-05-26 |
Zogenix International Limited |
Methods of treating Rett syndrome using fenfluramine
|
|
KR20220009954A
(ko)
|
2019-04-17 |
2022-01-25 |
컴퍼스 패쓰파인더 리미티드 |
신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
|
|
JP7730548B2
(ja)
*
|
2019-04-18 |
2025-08-28 |
プリヴェップ インコーポレイテッド |
治療用組合せ、液状の薬学的組成物、それらの調製のためのキット、およびこれらの使用方法
|
|
EP3972573A4
(en)
*
|
2019-05-23 |
2023-07-12 |
India Globalization Capital, Inc. |
COMPOSITIONS AND METHODS OF USING CANNABINOIDS TO TREAT STAMMING/STOMMING AND SYMPTOMS OF TOURETTE SYNDROME
|
|
BR112022003686A2
(pt)
|
2019-08-26 |
2022-05-24 |
Period Pill Bv |
Tratamento de sintomas induzidos pelo ciclo menstrual
|
|
US12014835B2
(en)
*
|
2020-02-19 |
2024-06-18 |
Vanderbilt University |
Methods for evaluating therapeutic benefit of combination therapies
|
|
RU2743876C1
(ru)
*
|
2020-05-19 |
2021-03-01 |
Татьяна Евгеньевна Ефремова |
Способ реабилитации детей и подростков с поведенческими и эмоциональными нарушениями, страдающих психическими расстройствами
|
|
US11612574B2
(en)
|
2020-07-17 |
2023-03-28 |
Zogenix International Limited |
Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
|
WO2022126114A1
(en)
*
|
2020-12-09 |
2022-06-16 |
Eysz, Inc. |
Systems and methods for monitoring and managing neurological diseases and conditions
|
|
GB202101462D0
(en)
*
|
2021-02-03 |
2021-03-17 |
Sanchez Hector Mario |
Combination therapy for treating executive function disorders
|
|
US20240197704A1
(en)
*
|
2021-04-09 |
2024-06-20 |
Johns Hopkins University |
Treatment methods and compositions comprising perampanel
|
|
AU2022269557A1
(en)
*
|
2021-05-05 |
2023-11-09 |
Mind Medicine, Inc. |
Mdma enantiomers
|
|
WO2022251703A2
(en)
|
2021-05-28 |
2022-12-01 |
Blinktbi, Inc. |
Systems and methods for eyelid localization
|
|
WO2022265534A1
(ru)
*
|
2021-06-18 |
2022-12-22 |
Гиви Иванович ИКАЕВ |
Способ коррекции психического состояния больного шизофренией
|
|
EP4366735A1
(en)
*
|
2021-07-08 |
2024-05-15 |
NLS Pharmaceutics AG |
Benedin, piperidine, 2-benzhydryl-3-hydroxy-n-methyl-, hydrochloride and derivatives thereof for use in treating kleine-levin syndrome
|
|
WO2023092044A2
(en)
|
2021-11-17 |
2023-05-25 |
Terran Biosciences, Inc. |
Phenethylamine compounds salts, polymorphic forms and methods of use thereof
|
|
WO2023107715A1
(en)
*
|
2021-12-09 |
2023-06-15 |
Tactogen Inc |
Specialized combinations for mental disorders or mental enhancement
|
|
US20250375129A1
(en)
*
|
2022-02-11 |
2025-12-11 |
Blinktbi, Inc. |
Use of blink reflex for attention-deficit/hyperactivity disorder (adhd) response monitoring and/or treatment selection
|
|
WO2024123706A1
(en)
*
|
2022-12-05 |
2024-06-13 |
Lykos Therapeutics, Inc. |
Compositions comprising mdma and methods of using same
|
|
CN116831580B
(zh)
*
|
2023-08-31 |
2023-12-01 |
北京中科心研科技有限公司 |
识别抑郁情绪障碍的计算设备应用、装置及可穿戴设备
|
|
US20250182612A1
(en)
*
|
2023-11-30 |
2025-06-05 |
Toyota Motor Engineering & Manufacturing North America, Inc. |
Systems and methods for providing assistance to hearing-impaired pedestrians
|
|
US12475781B2
(en)
|
2023-12-08 |
2025-11-18 |
Toyota Motor Engineering & Manufacturing North America, Inc. |
Systems and methods for detecting impaired decision-making pedestrians
|
|
WO2025196662A1
(en)
|
2024-03-20 |
2025-09-25 |
Clearmind Labs Corp. |
Compositions and methods for treating eating disorders
|
|
US12605388B2
(en)
|
2024-09-25 |
2026-04-21 |
Azurity Pharmaceuticals Ireland Limited |
Lamotrigine salts, co-crystals, and compositions
|